Comparison of Fingerstick Versus Venous Sample for Troponin I.

Completed

• Conditions: Chest Pain; Heart Attack; Myocardial Ischemia; Myocardial Infarction
• Interventions: Device: POC troponin analysis.

• Registration Number: NCT04153006
• Lead Sponsor: VieCuri Medical Centre

Brief Summary

This study is a prospective, observational, cohort study aiming to compare point-of-care high-sensitive troponin I testing from different sample types with central laboratory (CL) HS cTnI plasma samples.

A registry of all included patients and their troponin results (POC, CL and HS cTnT) will be made to compare these testing methods.

Detailed Description

Point-of-care (POC) troponin testing, defined as laboratory testing near a patient location with rapid availability of results, has attracted much interest in the emergency department setting (ED) and seems feasible. These devices might enable earlier decisions, reduce stay at the ED and improve patient flow. While an elevated troponin in patients with suspected acute coronary syndrome (ACS) confirms diagnosis and initiates adequate treatment, ruling out ACS aids in proper patient dismissal. A next step could be ruling out myocardial infarction by the general practitioner (GP) or fast responder using an on-site POC troponin test. However, drawing venous blood might not be easily available to every GP, especially not during peak hours. The Minicare cTnI is a bedside system which requires capillary blood, venous whole blood or plasma. The results of the troponin will be given within 10 minutes. It is a very sensitive troponin test, the most clinically sensitive available POC for c-Troponin. Currently Minicare prepares for a high sensitive troponin analysis targeting a reliable result within an hour after onset of chest pain. The objective of this study is to determine if high sensitive troponin testing by Minicare (POC HS cTnI) has the same analytical performance as standard high sensitivity troponin I testing in our central hospital laboratory ( CL HS cTnI ARCHITECT immunoassay analyzer, Abbott).

Study Timeline

• Study Start: 2019-09-03
• Study First Submitted: 2019-11-01
• Study First Submitted QC: 2019-11-01
• Study First Posted: 2019-11-06
• Primary Completion: 2020-03-13
• Study Completion: 2020-04-13
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-09
• Last Update Posted: 2022-06-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 131

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Chest pain patients	POC troponin analysis.	Patients who are admitted to the cardiac ED because of chest pain for ruling out acute coronary syndrome by troponin analysis are eligible for participation. Troponin analysis will be performed according to standard protocol (0-1h protocol). From every included patient capillary blood samples and an extra venous blood sample will be drawn to evaluate HS cTnI levels obtained with the POC instrument and central laboratory (CL).

Primary Outcome Measures

Name	Time	Method
Method and sample comparison	30 days	The primary objective is to compare the analytical performance (method and sample comparison) of Minicare® high sensitive troponin I testing (POC, different sample types) and conventional venipuncture troponin I test in our central hospital laboratory (CL) with the Abbott Architect.; This comparison will comprise: * Minicare® POC (different sample types) vs conventional HS cTnI CL test (Method comparison); * Minicare® capillary vs. Minicare® venipuncture and vs. Minicare® plasma (Sample comparison); The analyses linked to the primary objectives are: * The agreement between POC (three sample types) and CL testing by using the Bland-Altman method.; * The agreement between different POC sample types by using the Bland-Altman method.; The primary objective will be achieved by taking capillary and (an extra) venous blood samples (one per timepoint) from every patient presenting at the cardiac ED with chest pain suspected for ACS.

Secondary Outcome Measures

Name	Time	Method
Linear regression and Pearson's correlation.	30 days	* The relationship between POC (three sample types) and CL by linear regression and Pearson's correlation.; * The relationship between POC sample types by linear regression and Pearson's correlation.
Fals-positive and fals-negatives.	30 days	To compare the proportion of false positive and false negative results between the different POC samples and if there is a significant difference.
Major adverse cardiac event (MACE)	30 days	MACE is is defined as a composite of cardiac death and myocardial infarction.
Final patients diagnoses.	30 days	To compare final patients diagnosis (ACS vs. no ACS) and treatment based on POC venous troponin testing versus CL plasma troponin I testing versus HS cTnT plasma testing (regular patient care).
Safety analysis of POC troponin.	30 days	To create an overview of the sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of POC and standard laboratory troponin I testing.
Overview baseline characteristics.	30 days	To create an overview of baseline characteristics of the population.

Trial Locations

Locations (1)

Viecuri MC; 🇳🇱 Venlo, Limburg, Netherlands